Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

James M. Foran, MD, Michael Heckman, MS, Rhett P. Ketterling, MD, Lisa Sproat, MD MSW, Liuyan Jennifer Jiang, MD, Bruce Eckloff, PhD, Nancy Diehl, Laura E. Finn, MD, Keith Robertson, PhD, Raoul Tibes, MD PhD, James R. Cerhan, MD PhD, Yan W Asmann, PhD

Blood (2017) 130 (Supplement 1): 570.

https://doi.org/10.1182/blood.V130.Suppl_1.570.570

Published: 2017

Journal Articles

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Jeanne Palmer, MD, Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Nandita Khera, MD, Lisa Sproat, MD MSW, Pierre Noel, MD, James L. Slack, MD, Vivek Roy, MD, Jose F. Leis, MD PhD, William J. Hogan, MBBCh, Ayalew Tefferi, MD, Veena D. S. Fauble, MD, Mrinal M. Patnaik, MDMBBS, Heidi Elizabeth Kosiorek, MS, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 4598.

https://doi.org/10.1182/blood.V130.Suppl_1.4598.4598

Published: 2017

Journal Articles

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

Tania Jain, MD, Katie L. Kunze, PhD, Daniel K. Partain, MD, Heidi Kosiorek, MS, Vivek Roy, MD, Nandita Khera, MD, James L. Slack, MD, Mrinal M. Patnaik, MDMBBS, William J. Hogan, MBBCh, Pierre Noel, MD, Veena D. S. Fauble, MD, Jose F. Leis, MD PhD, Lisa Sproat, MD MSW, Ruben A Mesa, MD, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 4561.

https://doi.org/10.1182/blood.V130.Suppl_1.4561.4561

Published: 2017

Journal Articles

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

Kevin C. Miller, BS, Aref Al-Kali, MD, William J. Hogan, MBBCh, Michelle A. Elliott, MD, Kebede H. Begna, MD, Naseema Gangat, MBBS, Mrinal M. Patnaik, MDMBBS, Lisa Sproat, MD MSW, James M. Foran, MD, Mark R. Litzow, MD, Hassan B. Alkhateeb, MD

Blood (2017) 130 (Supplement 1): 5010.

https://doi.org/10.1182/blood.V130.Suppl_1.5010.5010

Published: 2017

Journal Articles

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Nandita Khera, MD, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Raoul Tibes, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5057.

https://doi.org/10.1182/blood.V130.Suppl_1.5057.5057

Published: 2017

Journal Articles

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Caleb J Scheckel, DO, Jeffrey Alan Betcher, BSPharm, RPh, Lisa Sproat, MD MSW, Raoul Tibes, James L. Slack, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Lanyu Mi, MS, Jeanne Palmer, MD

Blood (2017) 130 (Supplement 1): 5058.

https://doi.org/10.1182/blood.V130.Suppl_1.5058.5058

Published: 2017

Journal Articles

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies

Raoul Tibes, MD PhD, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Jeanne Palmer, MD, James L. Slack, MD, Emily Ann Knight, NP, Saman Khalid Hashmi, MD, James M. Bogenberger, PhD, Darci Zblewski, CNP, William J. Hogan, MBBCh, Mark R. Litzow, MD, Ruben A Mesa, MD, James M. Foran, MD, Lisa Sproat, MD MSW, Aref Al-Kali, MD

Blood (2017) 130 (Supplement 1): 2629.

https://doi.org/10.1182/blood.V130.Suppl_1.2629.2629

Published: 2017

Journal Articles

Acute Lymphoblastic Leukemia/Lymphoma in the Elderly: The Mayo Clinic Experience

Blood (2017) 130 (Supplement 1): 1294.

https://doi.org/10.1182/blood.V130.Suppl_1.1294.1294

Published: 2017

Journal Articles

Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben Mesa, MD FACP, Raoul Tibes, MD PhD

Blood (2016) 128 (22): 3948.

https://doi.org/10.1182/blood.V128.22.3948.3948

Published: 2016

Journal Articles

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study of 40,011 Patients

Natalie Ertz-Archambault, MD, Gretchen Taylor, MD, Heidi E. Kosiorek, MS, Amylou Constance Dueck, PhD, Janna Castro, Rob Marino, Susanne Gauthier, R.N., Katalin Kelemen, MD PhD, Laura E. Finn, MD, Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben Mesa, MD FACP, Aref Al-Kali, MD, James M. Foran, MD, Raoul Tibes, MD PhD

Blood (2016) 128 (22): 296.

https://doi.org/10.1182/blood.V128.22.296.296

Published: 2016

Journal Articles

Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML)

Amanda Shreders, MD, Michael Heckman, Dan Zhou, PhD, Man Yang, PhD, Laura E. Finn, MD, Lisa Sproat, MD MSW, Liuyan Jiang, MD, Nancy Diehl, Ryan Hlady, Rhett P. Ketterling, MD, Raoul Tibes, MD PhD, Keith D Robertson, PhD, James M. Foran, MD

Blood (2016) 128 (22): 1719.

https://doi.org/10.1182/blood.V128.22.1719.1719

Published: 2016

Journal Articles

Alvocidib Potentiates the Activity of Venetoclax in Preclinical Models of Acute Myeloid Leukemia

Clifford J. Whatcott, PhD, James M Bogenberger, PhD, Wontak Kim, Hillary Haws, Nanna Hansen, M.S., Devora Delman, B.S., Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben A. Mesa, MD, Peter Peterson, PhD, Adam Siddiqui-Jain, PhD, Steven Weitman, MD PhD, David J. Bearss, PhD, Steven L. Warner, PhD, Raoul Tibes, MD PhD

Blood (2016) 128 (22): 1652.

https://doi.org/10.1182/blood.V128.22.1652.1652

Published: 2016

Journal Articles

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Tania Jain, M.B.,B.S, M'hamed Temkit, Daniel K. Partain, MD, Mrinal M Patnaik, MBBS, James L. Slack, MD, Nandita Khera, MD, William J. Hogan, MBChB, Vivek Roy, MD, Pierre Noel, MD, Jose F Leis, MD PhD, Lisa Sproat, MD MSW, Veena DS Fauble, MD, Ruben A. Mesa, MD, Jeanne Palmer, MD

Blood (2016) 128 (22): 4653.

https://doi.org/10.1182/blood.V128.22.4653.4653

Published: 2016

Journal Articles

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies

Raoul Tibes, MD PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Lisa Sproat, MD MSW, Jeanne Palmer, MD, James L. Slack, MD, Devinder Singh, MD, Eileen Gebhart, MSN, RN, ANP-BC, Emily Knight, RN, Shahrukh K. Hashmi, MD, Ryan A Wilcox, MD PhD, James M Bogenberger, PhD, Ruben A. Mesa, Aref Al-Kali, MD

Blood (2015) 126 (23): 1347.

https://doi.org/10.1182/blood.V126.23.1347.1347

Published: 2015

Journal Articles

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study

Natalie Ertz-Archambault, MD, Heidi Kosiorek, M.S., Janna Castro, Gretchen Taylor, MD, Robert Marino, Amylou Constance Dueck, PhD, Aref Al-Kali, MD, Susanne Gauthier, R.N., Laura E. Finn, MD, James M. Foran, MD, Lisa Sproat, MD MSW, Raoul Tibes, MD PhD

Blood (2015) 126 (23): 5636.

https://doi.org/10.1182/blood.V126.23.5636.5636

Published: 2015

Journal Articles

A Single Institution Study of Allogeneic Hematopoietic Stem Cell Transplant for MDS and AML in Patients 60 Years of Age and Older: Impact of Disease Risk Index and Secondary Disease

Eva Gupta, MD, Randi Hoffman, Thomas Colleen, MS, William J Hogan, MBChB, Mark R Litzow, MD, Lisa Sproat, MD MSW, James M. Foran, MD, Laura E. Finn, MD, Vivek Roy, MD

Blood (2015) 126 (23): 5532.

https://doi.org/10.1182/blood.V126.23.5532.5532

Published: 2015

Journal Articles

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Aref Al-Kali, MD, Lisa Sproat, MD MSW, Jeffrey Alan Betcher, BSPharm, RPh, Jason N. Barreto, PharmD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Michelle Elliott, MD, Mark R Litzow, MD, William J Hogan, MBChB

Blood (2015) 126 (23): 4910.

https://doi.org/10.1182/blood.V126.23.4910.4910

Published: 2015

Journal Articles

Hematopoietic Stem Cell Transplantation As a Successful Salvage Strategy for Relapsed Acute Promyelocytic Leukemia (APL): A Mayo Clinic Series

Gita Thanarajasingam, MD, James M. Foran, MD, Vivek Roy, MD, Lisa Sproat, MD MSW, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD, Naseema Gangat, MD, Mrinal M. Patnaik, MBBS

Blood (2014) 124 (21): 3995.

https://doi.org/10.1182/blood.V124.21.3995.3995

Published: 2014

Journal Articles

Does Allogeneic Hematopoietic Cell Transplantation Benefit Older (≥ 60) AML/MDS Patients With Monosomal Karyotype?

James L Slack, MD, Nandita Khera, MD, MPH, Veena Fauble, MD, Jose F Leis, MD, PhD, Lisa Sproat, MD, MSW, Jared Klein, MD, Craig B. Reeder, MD, Jeffrey A Betcher, R.Ph., Pierre Noel, MD

Blood (2013) 122 (21): 3399.

https://doi.org/10.1182/blood.V122.21.3399.3399

Published: 2013

Journal Articles

The Wee1 Inhibitor MK1775 In Combination With Cytarabine (AraC) Has Potent Activity In AML By Completely Abrogating DNA Damage and Cell Cycle Checkpoint Repair Capacity Via The Mrn/NBS1 Complex

Leena Chaudhuri, PhD, James M Bogenberger, PhD, Lisa Sproat, MD, MSW, James L Slack, MD, Veena Fauble, MD, Raoul Tibes, MD, PhD

Blood (2013) 122 (21): 3831.

https://doi.org/10.1182/blood.V122.21.3831.3831

Published: 2013

NARROW

Molecular Epidemiology of Acute Myeloid Leukemia (AML): Novel Association of Clinical Epidemiologic Exposures with Unique Mutation Groups on Exome Sequencing of Leukemia DNA in the Mayo Clinic AML Epidemiology Cohort

Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis

Transfusion Dependence at Day +100 Predicts Poorer Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation for Myelofibrosis

Therapy-Related Acute Lymphoblastic Leukemia/Lymphoma in the Elderly

A Single Center Analysis of Clofarabine Use Prior to Bone Marrow Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Comparison of Mitoxantrone-Based Salvage Therapies (MEC vs CLAG-M) in Relapsed or Refractory Acute Myeloid Leukemia

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition with Sonidegib (LDE225) in Myeloid Malignancies

Acute Lymphoblastic Leukemia/Lymphoma in the Elderly: The Mayo Clinic Experience

Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study of 40,011 Patients

Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML)

Alvocidib Potentiates the Activity of Venetoclax in Preclinical Models of Acute Myeloid Leukemia

Day +30 and Day +100 CD33 Chimerisms Predict Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelofibrosis

Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies

Myelodysplastic Syndromes and Acute Myelogenous Leukemia Resulting from Therapy for Autoimmune Disease, a Case-Control Cohort Study

A Single Institution Study of Allogeneic Hematopoietic Stem Cell Transplant for MDS and AML in Patients 60 Years of Age and Older: Impact of Disease Risk Index and Secondary Disease

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Hematopoietic Stem Cell Transplantation As a Successful Salvage Strategy for Relapsed Acute Promyelocytic Leukemia (APL): A Mayo Clinic Series

Does Allogeneic Hematopoietic Cell Transplantation Benefit Older (≥ 60) AML/MDS Patients With Monosomal Karyotype?

The Wee1 Inhibitor MK1775 In Combination With Cytarabine (AraC) Has Potent Activity In AML By Completely Abrogating DNA Damage and Cell Cycle Checkpoint Repair Capacity Via The Mrn/NBS1 Complex

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only